Masaya Hashimoto

914 total citations
30 papers, 698 citations indexed

About

Masaya Hashimoto is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Masaya Hashimoto has authored 30 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 8 papers in Cellular and Molecular Neuroscience and 7 papers in Molecular Biology. Recurrent topics in Masaya Hashimoto's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological disorders and treatments (6 papers) and Genetic Neurodegenerative Diseases (4 papers). Masaya Hashimoto is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological disorders and treatments (6 papers) and Genetic Neurodegenerative Diseases (4 papers). Masaya Hashimoto collaborates with scholars based in Japan, Germany and United States. Masaya Hashimoto's co-authors include Masahiko Suzuki, Mitsuyoshi Urashima, Masayuki Yoshioka, M Murakami, Daisuke Takahashi, Keiichi Kawasaki, Kenji Ishii, Kiichi Ishiwata, Yuichi Kimura and Keiichi Oda and has published in prestigious journals such as PLoS ONE, American Journal of Clinical Nutrition and Journal of Medicinal Chemistry.

In The Last Decade

Masaya Hashimoto

29 papers receiving 679 citations

Peers

Masaya Hashimoto
Karen Frei United States
S.Y. Lum Singapore
Daniel Kremens United States
Oren Cohen Israel
Xiao Deng Singapore
Melissa A. Plone United States
Masaya Hashimoto
Citations per year, relative to Masaya Hashimoto Masaya Hashimoto (= 1×) peers Osamu Kano

Countries citing papers authored by Masaya Hashimoto

Since Specialization
Citations

This map shows the geographic impact of Masaya Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaya Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaya Hashimoto more than expected).

Fields of papers citing papers by Masaya Hashimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaya Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaya Hashimoto. The network helps show where Masaya Hashimoto may publish in the future.

Co-authorship network of co-authors of Masaya Hashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Masaya Hashimoto. A scholar is included among the top collaborators of Masaya Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaya Hashimoto. Masaya Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hashimoto, Masaya, et al.. (2018). Proposal of Electronic Component Visual Inspection Method with Histogram-Based Local Feature. Journal of the Japan Society for Precision Engineering. 84(7). 664–670. 2 indexed citations
3.
Nagayama, Hiroshi, Tetsuya Maeda, Tsuyoshi Uchiyama, et al.. (2016). Anhedonia and its correlation with clinical aspects in Parkinson's disease. Journal of the Neurological Sciences. 372. 403–407. 24 indexed citations
4.
Kubo, Shinichiro, Shinsuke Hamada, Tetsuya Maeda, et al.. (2016). A Japanese multicenter survey characterizing pain in Parkinson's disease. Journal of the Neurological Sciences. 365. 162–166. 5 indexed citations
5.
Hashimoto, Masaya, et al.. (2013). A case of isolated hypoglossal nerve palsy with acute lymphoblastic leukemia. Rinsho Shinkeigaku. 53(3). 243–246.
6.
Suzuki, Masahiko, Masayuki Yoshioka, Masaya Hashimoto, et al.. (2013). Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. American Journal of Clinical Nutrition. 97(5). 1004–1013. 166 indexed citations
7.
Hashimoto, Masaya, et al.. (2012). A 20-year-old female with Hirayama disease complicated with dysplasia of the cervical vertebrae and degeneration of intervertebral discs. BMJ Case Reports. 2012. bcr2012006885–bcr2012006885. 4 indexed citations
8.
Suzuki, Masahiko, Masayuki Yoshioka, Masaya Hashimoto, et al.. (2011). 25‐hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson's disease. Movement Disorders. 27(2). 264–271. 84 indexed citations
9.
Mishina, Masahiro, Kiichi Ishiwata, Mika Naganawa, et al.. (2011). Adenosine A2A Receptors Measured with [11C]TMSX PET in the Striata of Parkinson's Disease Patients. PLoS ONE. 6(2). e17338–e17338. 104 indexed citations
10.
Ishiwata, Kiichi, Yuichi Kimura, Keiichi Oda, et al.. (2010). Development of PET radiopharmaceuticals and their clinical applications at the Positron Medical Center. Geriatrics and gerontology international. 10(s1). S180–96. 7 indexed citations
11.
Hashimoto, Masaya, Keiichi Kawasaki, Masahiko Suzuki, et al.. (2008). Presynaptic and postsynaptic nigrostriatal dopaminergic functions in multiple system atrophy. Neuroreport. 19(2). 145–150. 13 indexed citations
12.
Okamoto, Osamu, Kensuke Kobayashi, Hiroshi Kawamoto, et al.. (2008). Novel ORL1-selective antagonists with oral bioavailability and brain penetrability. Bioorganic & Medicinal Chemistry Letters. 18(11). 3282–3285. 8 indexed citations
13.
Fukumitsu, Nobuyoshi, Kenji Ishii, Yuichi Kimura, et al.. (2008). Adenosine A1 receptors using 8-dicyclopropylmethyl-1-[11C]methyl-3-propylxanthine PET in Alzheimer’s disease. Annals of Nuclear Medicine. 22(10). 841–847. 35 indexed citations
14.
Okamoto, Osamu, Kensuke Kobayashi, Hiroshi Kawamoto, et al.. (2008). Identification of novel benzimidazole series of potent and selective ORL1 antagonists. Bioorganic & Medicinal Chemistry Letters. 18(11). 3278–3281. 10 indexed citations
15.
Ishii, Kenji, Masaya Hashimoto, Yuichi Kimura, et al.. (2008). IC‐P2‐103: Direct comparison of in vivo accumulation of 11C‐PIB and 11C‐BF227 in Alzheimer's disease. Alzheimer s & Dementia. 4(4S_Part_2). 1 indexed citations
16.
Suzuki, Masahiko, et al.. (2007). Cardiac sympathetic denervation in bradykinesia-dominant Parkinson's disease. Neuroreport. 18(17). 1867–1870. 29 indexed citations
17.
Shimada, Hiroyuki, Yuichi Kimura, Takao Suzuki, et al.. (2007). The Use of Positron Emission Tomography and $[^{18}{\rm F}]$Fluorodeoxyglucose for Functional Imaging of Muscular Activity During Exercise With a Stride Assistance System. IEEE Transactions on Neural Systems and Rehabilitation Engineering. 15(3). 442–448. 19 indexed citations
18.
Fukase, Koichi, Mikayo Kataoka, Masaya Hashimoto, Yasuo Suda, & Shoichi Kusumoto. (2006). Synthesis and Biological Activities of Biscarboxymethyl Lipid A Analogues. Heterocycles. 69(1). 395–395. 5 indexed citations
19.
Suzuki, Masahiko, Akira Kurita, Masaya Hashimoto, et al.. (2005). Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: Comparison between dementia with Lewy bodies and Parkinson's disease. Journal of the Neurological Sciences. 240(1-2). 15–19. 58 indexed citations
20.
Seydel, Ulrich, Andra B. Schromm, Lore Brade, et al.. (2004). Physicochemical characterization of carboxymethyl lipid A derivatives in relation to biological activity. FEBS Journal. 272(2). 327–340. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026